GenSight: Goldman Sachs exceeds 5% threshold
This crossing of thresholds results from an off-market acquisition of GenSight Biologics shares and an increase in the number of shares held by assimilation. Goldman Sachs International crossed the same thresholds individually.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction